But Wait…There’s More! (Part 1)
“Peeling the Onion” is a monthly column by Harvey Abrams, PhD. As widely reported, President Donald Trump signed the FDA Reauthorization Act into law on August 18th. As part of this law, the Food and Drug Administration (FDA) is directed to create and regulate a new category of hearing aids that can be sold…
Read More
Relationship between OTC Price and Behavioral Performance: A Guiding Light
by Amyn Amlani, PhD The reality of over-the-counter (OTC) products becoming federally regulated took one step closer to certainty last week. The FDA Reauthorization Act of 2017 (HR 2430), which includes provisions for OTC hearing aids for adults with perceived mild-to-moderate hearing loss, passed successfully through the US House of Representatives in July 2017…
Read MoreThe Plural of Anecdote is NOT Data
by Harvey Abrams, PhD. “Peeling the Onion” is a monthly column by Harvey Abrams, PhD. I participated in two events this week. One informed the other. The first event was the Federal Trade Commission (FTC) Workshop held in Washington DC on April 18th. The other was the March for Science which, in my current geographical…
Read MorePlease, No More Shoes!
by Harvey Abrams, PhD. “Peeling the Onion” is a monthly column by Harvey Abrams, PhD. As we all know by now, the third shoe (or was it a boot) dropped with a loud thud heard ’round the industry. The FDA appears to be investigating the feasibility of creating a new category of basic hearing aids that…
Read More
Let’s Hear It From the Providers
Amidst technological disruption and social policy discussions that cast a pall over the dispensing landscape, it is surprisingly refreshing to hang out with fellow travellers. That term, often a pejorative, best describes the relationship of Hearing Economics to the world of audiology and hearing aids: “a person who sympathizes with the beliefs of an organization…
Read More